Stories about P110α
-
Language:
English
-
Media:
All
- Period:
- Period:Total
- more
Sysmex Inostics announces first results of tissue-independent liquid biopsy for early stage breast cancer mutation characterization and monitoring using ultra-sensitive SafeSEQ technology
moreSysmex Inostics launches two NGS-based liquid biopsy panels for cancer therapy drug development
moreSysmex Inostics' SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM(TM) enhanced digital PCR technology for detection of mutations in circulating tumor DNA
more
1